The Protective Potential Role of ACE2 against COVID-19

Fereshteh Golab1, Gelareh Vahabzadeh2, Leila SadeghRoudbari1

  • 1Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

PubMed

Insights

This review explores how angiotensin-converting enzyme 2 (ACE2) acts as a crucial receptor for SARS-CoV-2 infection. Understanding ACE2's role in COVID-19 pathogenesis may lead to new therapeutic strategies.

Area of Science:

  • Virology
  • Cardiovascular Research
  • Infectious Diseases

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic necessitates urgent therapeutic development.
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes angiotensin-converting enzyme 2 (ACE2) as a key receptor for cell entry and infection.
  • ACE2 downregulation by the SARS-CoV-2 spike protein triggers detrimental angiotensin II (Ang II)/angiotensin type 1 receptor axis overactivation.

Purpose of the Study:

  • To review the critical role of ACE2 in SARS-CoV-2 infection.
  • To explore the potential protective mechanisms of ACE2 against viral infection.
  • To provide insights for developing novel COVID-19 prevention and control strategies.

Main Methods:

  • Literature review of existing research on ACE2, SARS-CoV-2, and COVID-19 pathogenesis.
  • Analysis of the molecular interactions between SARS-CoV-2 spike protein and ACE2.
  • Examination of the physiological consequences of ACE2 downregulation in COVID-19.

Main Results:

  • ACE2 is essential for SARS-CoV-2-mediated cell fusion and infection.
  • Downregulation of ACE2 leads to harmful Ang II/AT1R axis overactivation, contributing to organ dysfunction in COVID-19 patients.
  • The widespread distribution of ACE2 contributes to the diverse symptoms and complications observed in COVID-19.

Conclusions:

  • ACE2 plays a dual role as a viral receptor and a critical regulator of the renin-angiotensin system.
  • Targeting ACE2 or its related pathways may offer a protective strategy against SARS-CoV-2 infection.
  • Further research into ACE2's function is vital for developing effective COVID-19 therapeutics and control measures.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
703
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
711
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
470
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
790
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K